FLT3 IAP A pharmaceutical combination comprising FLT3 inhibitor and IAP antagonist for the treatment of the acute myeloid leukemia

摘要

Fms-like tyrosine kinase-3 (FLT3) inhibitor, or a pharmaceutically acceptable salt or solvate thereof, and an inhibitor of apoptosis protein (IAP) antagonist, or its It provides a pharmaceutical combination for the treatment of acute myeloid leukemia (AML), and a method for treating acute myelogenous leukemia using the same, comprising a pharmaceutically acceptable salt or solvate in a therapeutically effective combination.